News

Banking on robust above-market growth across all business units, BSX is expected to have witnessed strong international momentum in the first quarter.
Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...
Needham upgraded Boston Scientific Corp (NYSE:BSX) to “Buy”, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was earlier feared, and citing ...
RBC Capital is still sweet on Boston Scientific, holding firm on its $116 price target and an Outperform rating. The analyst ...
We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will ...